{
    "organizations": [],
    "uuid": "6f3010af869dc8899d68c6e0ba1dacae958e7cb6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-egyptian-international-pharmaceuti/brief-egyptian-international-pharmaceuticals-fy-standalone-profit-rises-idUSFWN1Q50AB",
    "ord_in_thread": 0,
    "title": "BRIEF-Egyptian International Pharmaceuticals FY Standalone Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - EGYPTIAN INTERNATIONAL PHARMACEUTICALS INDUSTRIES CO:\n* FY STANDALONE NET PROFIT EGP 651.5 MILLION VERSUS EGP 469 MILLION YEAR AGO\n* FY STANDALONE NET SALES EGP 2.48 BILLION VERSUS EGP ‍1.94​ BILLION YEAR AGO\n* PROPOSES EGP 357 MILLION IN FY DIVIDEND Source: ( bit.ly/2HhCsSa ) Further company coverage:\n ",
    "published": "2018-02-15T16:08:00.000+02:00",
    "crawled": "2018-02-16T16:45:22.052+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "egyptian",
        "international",
        "pharmaceutical",
        "industry",
        "co",
        "fy",
        "standalone",
        "net",
        "profit",
        "egp",
        "million",
        "versus",
        "egp",
        "million",
        "year",
        "ago",
        "fy",
        "standalone",
        "net",
        "sale",
        "egp",
        "billion",
        "versus",
        "egp",
        "billion",
        "year",
        "ago",
        "proposes",
        "egp",
        "million",
        "fy",
        "dividend",
        "source",
        "company",
        "coverage"
    ]
}